Basal cell carcinoma is a slow-growing malignant skin tumor and its often found in elderly patients on sun exposed areas that confirming chronic UV radiation. Demographic, clinical and histological characteristics of the patients have been analyzed of nodular type of basal cell carcinoma in order to determine correlation between localization, duration and tumor size. Database was searched for medical records of patients with nodular BCC evaluated in Health Center of Kosovska Mitrovica and Clinical Center of Nis during the period of 2006 through 2008 year with the focus on demographic characteristics, localization, duration, size and clinical and histological characteristics of the tumor. Results: 36 patients with nodular BCC, 14 female and 22 male, in average old between 72.5±7.26 years of age. Two thirds of patients is older than 60 years and only 3 (8.33%) male patients are younger than 60 years of age. 72.11% of patients living in rural areas unlike 27.77% that lives in urban areas. Nodular type is occurring more often in males on skin of frontal and zygomatical region and in females on zygomatic and nose region. We found that the size of the tumor is in close correlation with length of duration of illness. Nodal BCC is more common in elderly male patients. Nodular type is occurring more often in males on skin of frontal and zygomatical region with a different distribution among women.
Wade TR, Ackerman AB. *The many faces of basal-cell carcinoma.*. *Journal of Dermatologic Surgery and Oncology,*. 1978;4:23–8.
2.
Lever W. *Lever’s Histopathology of the Skin*. 2005;805–66.
3.
Sahl WJ, Snow SN, Levine NS. *Giant basal cell carcinoma: Report of two cases and review of the literature.*. *Journal of the American Academy of Dermatology,*. 1994;30(5):856–9.
4.
Chen CC, Chen CL. *Clinical and histopathological findings of superficial basal cell carcinoma: A comparison with other basal cell carcinoma subtypes.*. *Journal of the Chinese Medical Association,*. 2006;69(8):364–71.
5.
Bower CP, Lear JT, Bygrave S, Etherington D, Harvey I, Archer CB. *Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England.*. *Journal of the American Academy of Dermatology,*. 2000;42:988–91.
6.
Hannuksela-Svahn A, Pukkala E, Karvonen J. *Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.*. *Archives of Dermatology,*. 1999;135:781–6.
7.
Harris RB, Griffith K, Moon TE. *Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1986.*. *Journal of the American Academy of Dermatology,*. 2001;45:528–36.
8.
Staples M, Marks R, Giles G. *Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–95: Are primary prevention programs starting to have an effect?*. *International Journal of Cancer,*. 1998;78:144–8.
9.
Scrivener Y, Grosshans E, Cribier B. *Variations of basal cell carcinomas according to gender, age, location and histopathological subtype.*. *British Journal of Dermatology,*. 2002;147:41–7.
10.
Armstrong BK, Kricker A. *The epidemiology of UV-induced skin cancer.*. *Journal of Photochemistry and Photobiology B: Biology,*. 2001;63:8–18.
11.
Fry RJM. *Principles of cancer biology: Physical carcinogenesis.*. In: *Cancer: Principles and Practice of Oncology*. 1989. p. 101–12.
12.
Upton A. *Etiology of skin cancer: radiation.*. In: *Medical Oncology: Basic Principles and Clinical Management of Cancer*. 1993. p. 107–20.
13.
Lukas R, McMichael A, Armstrong B, Smith W. *Estimating the global disease burden due to ultraviolet radiation exposure.*. *International Journal of Epidemiology,*. 2008;37(3):654–67.
14.
LeBoit PE, Burg G, Weedon D, Sarasin. A. 2006.
15.
Jacobs GH, Rippey JJ, Altini M. *Prediction of aggressive behaviour in basal cell carcinoma.*. *Cancer,*. 1982;49:533–7.
16.
Jacob A. *Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face.*. *Dublin Hospital Reports,*. 1824;4:232–9.
17.
Dicker T, Siller G, Saunders N. *Molecular and cellular biology of basal cell carcinoma.*. *Australasian Journal of Dermatology,*. 2002;43:241–6.
18.
Gruijl FR, Kranen HJ, Mullenders LH. *UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer.*. *Journal of Photochemistry and Photobiology B: Biology,*. 2001;63:19–27.
19.
Weinstock MA, Coulter S, Bates J, Bogaars HA, Larson PL, Burmer GC. *Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.*. *Archives of Dermatology,*. 1995;131:701–4.
20.
Barr BBB, McLaren K, Smith IW, Bunney MH, Blessing K. *Human papilloma virus infection and skin cancer in renal allograft recipients.*. *The Lancet,*. 1989;1:124–9.
21.
Wong SS, Tan KC, Goh CL. *Cutaneous manifestations of chronic arsenicism: review of seventeen cases.*. *Journal of the American Academy of Dermatology,*. 1998;38:179–85.
22.
Yu HS, Liao WT, Chai CY. *Arsenic carcinogenesis in the skin.*. *Journal of Biomedical Science,*. 2006;13(5):657–66.
23.
Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. *Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. In: The New Hampshire Skin Cancer Study Group* *Archives of Dermatology,*. 2000. p. 1007–11.
24.
Mithoefer AB, Supran S, Freeman RB. *Risk factors associated with the development of skin cancer after liver transplantation.*. *Liver Transplantation,*. 2002;8:939–44.
25.
Tran H, Chen K, Shumack S. *Epidemiology and aetiology of basal cell carcinoma.*. *British Journal of Dermatology,*. 2003;149(Suppl 66):50–2.
26.
Grossman D, Leffell DJ. *The molecular basis of nonmelanoma skin cancer: new understanding.*. *Archives of Dermatology,*. 1997;133:1263–70.
27.
Tavin E, Persky MS, Jacobs J. *Metastatic basal cell carcinoma of the head and neck.*. *Laryngoscope,*. 1995;105:814–7.
28.
Lo JS, Snow SN, Reizner GT. *Metastatic basal cell carcinoma: report of twelve cases with a review of the literature.*. *Journal of the American Academy of Dermatology,*. 1991;24:715–9.
29.
Lear JT, Hoban P, Strange RC, Fryer AA. *Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.*. *Clinical and Experimental Dermatology,*. 2005;30:49–55.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
